EverSource Wealth Advisors’s iRadimed IRMD Stock Holding History

EverSource Wealth Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.21K	Sell	23 -109	-83%	-$10.9K	﹤0.01%	3611
2025 Q4	$12.8K	Buy	132 +65	+97%	+$5.58K	﹤0.01%	2674
2025 Q3	$4.77K	Sell	67 -10	-13%	-$666	﹤0.01%	3168
2025 Q2	$4.6K	Buy	77 +53	+221%	+$2.9K	﹤0.01%	3192
2025 Q1	$1.26K	Buy	24 +8	+50%	+$449	﹤0.01%	3145
2024 Q4	$880	Buy	+16	New	+$842	﹤0.01%	3009

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EverSource Wealth Advisors's IRMD Position: Q1 2026 in Review

EverSource Wealth Advisors reduced its iRadimed (IRMD) stake by 83% in Q1 2026, selling an estimated $10.9K and leaving 23 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #3611.

EverSource Wealth Advisors first reported a position in IRMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.8K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

EverSource Wealth Advisors held 23 shares of iRadimed worth $2.21K as of Q1 2026.
EverSource Wealth Advisors sold 109 iRadimed shares in Q1 2026, an estimated $10.9K.
iRadimed made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3611 holding.
EverSource Wealth Advisors first reported a position in iRadimed in Q4 2024 and has held it in 6 quarters since.
EverSource Wealth Advisors's iRadimed position peaked at $12.8K in Q4 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.